tiprankstipranks
Cardinal Health (CH:CLH)
NYSE:CLH

Cardinal Health (CLH) Price & Analysis

0 Followers

CLH Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

Bulls Say, Bears Say

Bulls Say
Strong Free Cash FlowConsistent, large operating and free cash flow provides durable internal funding for operations, M&A, buybacks and debt paydown. Over the next 2–6 months strong cash conversion supports strategic flexibility despite leverage and smooths timing-driven working-capital swings.
High-growth Specialty & Adjacent BusinessesRapid growth in Specialty and adjacent businesses diversifies revenue away from low-margin wholesale distribution. Higher-growth, higher-margin segments and successful integrations (ADS, Solaris/GIA onboarding) change long-term mix and can sustainably lift company profitability and resilience.
Scale And Distribution ReachVery large scale and deep customer relationships create durable competitive advantages in purchasing, service levels and logistics. Scale supports thin distributor economics by enabling favorable supplier terms and broad coverage, underpinning stable core revenue over months ahead.
Bears Say
Weak Balance Sheet / Negative EquityPersistently negative equity and sizable absolute debt reduce financial flexibility and raise refinancing, covenant and rating risks. Over a 2–6 month horizon a thin capital cushion constrains capacity for opportunistic investment and increases vulnerability to macro or policy shocks.
Structurally Thin MarginsVery low distributor margins mean small adverse moves in pricing, reimbursement, tariffs or SG&A can materially depress profitability. Even with recent profit improvement, the business remains margin-sensitive and exposed to cost or mix shifts over the medium term.
Tariff & Asset Impairment RisksA goodwill impairment on Navista signals execution or valuation stress in parts of the MSO strategy, while large tariff payments and uncertain refunds create recurring cash and profit volatility. Regulatory and tariff outcomes pose persistent downside to segment earnings.

Cardinal Health News

CLH FAQ

What was Cardinal Health’s price range in the past 12 months?
Currently, no data Available
What is Cardinal Health’s market cap?
Cardinal Health’s market cap is CHF44.84B.
    When is Cardinal Health’s upcoming earnings report date?
    Cardinal Health’s upcoming earnings report date is Oct 30, 2026 which is in 80 days.
      How were Cardinal Health’s earnings last quarter?
      Cardinal Health released its earnings results on Aug 11, 2026. The company reported $2.357 earnings per share for the quarter, beating the consensus estimate of $1.96 by $0.397.
        Is Cardinal Health overvalued?
        According to Wall Street analysts Cardinal Health’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Cardinal Health pay dividends?
          Cardinal Health does not currently pay dividends.
          What is Cardinal Health’s EPS estimate?
          Cardinal Health’s EPS estimate is 2.35.
            How many shares outstanding does Cardinal Health have?
            Cardinal Health has 234,205,860 shares outstanding.
              What happened to Cardinal Health’s price movement after its last earnings report?
              Cardinal Health reported an EPS of $2.357 in its last earnings report, beating expectations of $1.96. Following the earnings report the stock price went same N/A.
                Which hedge fund is a major shareholder of Cardinal Health?
                Currently, no hedge funds are holding shares in CH:CLH
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Cardinal Health

                  Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

                  Cardinal Health (CLH) Earnings & Revenues

                  CLH Company Deck

                  CLH Earnings Call

                  Q3 2026
                  0:00 / 0:00
                  Earnings Call Sentiment|Positive
                  The call highlighted broad-based operational strength: solid top-line growth, outsized EPS improvement, robust free cash flow generation, meaningful outperformance in Specialty and other growth businesses, and a raised, narrowed FY26 outlook. Challenges noted include a $184M goodwill impairment for Navista, tariff-related pressure in the GMPD business with uncertain refunds (paid ~ $200M to date), higher headline SG&A and rising interest costs, and revenue mix headwinds from IRA/WAC adjustments and GLP-1 moderation. On balance the company emphasized durable fundamentals, disciplined capital deployment (including $1B of buybacks), successful integration of acquisitions and confidence in long-term targets.View all CH:CLH earnings summaries

                  CLH Revenue Breakdown

                  91.94%91.94%5.68%2.42%-0.04%
                  91.94% Pharmaceutical and Specialty Solutions
                  5.68% Global Medical Products and Distribution
                  2.42% Other
                  -0.04% Corporate
                  tipranks

                  CLH Stock 12 Month Forecast

                  Average Price Target

                  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
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Cencora
                  Henry Schein
                  McKesson
                  Prestige Consumer Healthcare
                  Popular Stocks